September 24, 2017 2:47 PM ET

Biotechnology

Company Overview of Tizona Therapeutics, Inc.

Company Overview

Tizona Therapeutics, Inc. develops immunotherapies. Its products include Anti-CCR4 antibody for the treatment of cancer, IL-35 antagonists for the treatment of cancer, and IL-35 agonists for the treatment of autoimmune diseases. The company was incorporated in 2014 and is based in South San Francisco, California.

601 Gateway Boulevard

Suite 350

South San Francisco, CA 94080

United States

Founded in 2014

Key Executives for Tizona Therapeutics, Inc.

Co-Founder, Chief Executive Officer, President and Director
Age: 54
Compensation as of Fiscal Year 2017.

Tizona Therapeutics, Inc. Key Developments

Tizona Therapeutics, Inc. Presents at 2016 BIO Investor Forum, Oct-18-2016 09:00 AM

Tizona Therapeutics, Inc. Presents at 2016 BIO Investor Forum, Oct-18-2016 09:00 AM. Venue: Westin St. Francis Hotel, 335 Powell Street, San Francisco, CA 94102, United States. Speakers: Pablo J. Cagnoni, Co-Founder, Chief Executive Officer, President and Director.

Tizona Therapeutics, Inc. Presents at BioNetwork West Partnering Summit 2016, Oct-06-2016 02:20 PM

Tizona Therapeutics, Inc. Presents at BioNetwork West Partnering Summit 2016, Oct-06-2016 02:20 PM. Venue: The Ritz-Carlton, Laguna Niguel, California, United States. Speakers: Jeremy Bender, Chief Operating Officer.

Tizona Therapeutics Appoints George Golumbeski to the Board of Directors

Tizona Therapeutics reported that George Golumbeski, Ph.D., has joined the company's board of directors. Dr. Golumbeski brings more than 25 years of executive leadership experience in R&D and business development in the biotechnology and pharmaceutical industry to Tizona. Dr. Golumbeski currently serves as Executive Vice President of Business Development for Celgene Corp.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3Bar Biologics Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Tax Management Inc United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Tizona Therapeutics, Inc., please visit tizonatx.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.